Terumo and Corazon Sign Collaboration and Co-Marketing Agreement

28 February 2022 | Monday | News


- Alignment signals recognition of Terumo Health Outcomes' proprietary ePRISM® technology using precision medicine to improve outcomes for cardiac patients and Corazon accreditation as a means to monitor and recognize such improvements
Image Source : Public Domain

Image Source : Public Domain

Terumo Health Outcomes, a division of Terumo Medical Corporation, a leading global medical device manufacturer, has signed a collaboration and co-marketing agreement with Corazon, Inc., a leader in providing consulting, recruitment, interim management and accreditation services for heart, vascular, neuroscience and orthopedic specialty programs.

 

Terumo Health Outcomes' platform, ePRISM®, employs complex algorithms to predict – on an individual basis – patients who may have an unanticipated outcome following a cardiac procedure. Armed with this knowledge, clinicians can make informed treatment decisions pre-procedure that prevent complications and lead to better outcomes. In turn, Corazon's unique E3® approach to accreditation allows customers to realize better quality cardiac care programs based on precision medicine.

"This partnership solidifies Terumo's presence in the digital healthcare arena. We are delighted that Corazon recognizes in our ePRISM technology and care pathways consulting an opportunity to partner to deliver innovative solutions that provide healthcare systems and practitioners with pre-procedure, patient-specific data that improves patient outcomes and lowers healthcare delivery costs," said Ryan Graver, Divisional Vice President of Terumo Health Outcomes.

"Corazon always seeks to identify leading-edge solutions for our clients that advance not only patient care, but also healthcare efficiency. By deploying individualized data analytics, together, Corazon and Terumo will provide new insights that guide programs forward in today's ever-changing healthcare environment, particularly within the key cardiovascular service line. More specifically, we believe we can enhance our accreditation services to add a new level of predictive analytics to care delivery, further improving patient outcomes," said Karen Hartman, President and CEO of Corazon.

Terumo and Corazon share a common mission to improve patient care through innovation and expertise. In bringing both solutions to customers this partnership creates synergies around excellence in processes of care, financial performance and most importantly, patient outcomes.

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close